Aethlon Medical Inc (AEMD)

Healthcare | Medical Devices
Income Statement (Quarterly) 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Revenue 0 0 0 0
Cost of Revenue 154,907 0 0 0
Gross Profit -154,907 0 0 0
Operating Expenses
R&D Expenses 0 0 0 0
SG&A Expenses 1,211,390,000 5,459,935,000 1,815,000 2,902,000
Operating Expenses 1,637,483 2,003,963 1,815,000 2,902,000
Operating Income -1,792,390 7,338,000 -1,815,000 -2,902,000
Interest Expense 0 10,109 0 0
Income Before Tax -1,761,858 -6,254,893 -1,755,000 -2,807,000
Income Tax Expense 0 0 0 0
Net Income -1,761,858 -6,254,893 -1,755,000 -2,807,000
Per Share
EPS -0.85 -4.01 -0.13 -0.20
EPS Diluted 0.00 0.00 0.00 0.00
Income Statement (Annual) 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Revenue 0 0 574,245 294,165 659,104
Cost of Revenue 339,559 359,057 265,300 154,217 0
Gross Profit -339,559 -359,057 308,945 139,948 0
Operating Expenses
R&D Expenses 0 0 0 0 0
SG&A Expenses 3,243,181 9,758,000 12,473,000 10,715,050 8,549,023
Operating Expenses 9,341,365 12,278,000 12,615,000 10,715,050 0
Operating Income -9,341,365 -12,637,000 -11,899,000 -10,420,885 -7,889,919
Interest Expense 10,109 0 0 -123,685 1,580
Income Before Tax -13,388,089 -12,208,000 -12,030,000 -10,420,885 -7,891,499
Income Tax Expense 0 3 0 -4,794 0
Net Income -13,388,089 -12,208,000 -12,030,000 -10,416,091 -7,886,709
Per Share
EPS -8.58 -4.86 -5.86 -7.06 -0.65
EPS Diluted 0.00 0.00 0.00 0.00 0.00
Balance Sheet (Quarterly) 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Assets
Cash and Cash Equivalents 5,501,261 5,441,978 14,532,943 17,072,419
Short Term Investments 0 0 0 0
Net Receivables 0 0 0 127,965
Inventory 0 0 0 0
Total Current Assets 5,949,800 6,225,788 15,090,566 18,157,007
Property Plant Equipment 1,278,066 1,898,283 2,295,913 1,137,936
Goodwill and Intangibles 550 1,100 1,650 2,200
Total Assets 7,359,534 8,245,982 17,508,940 19,417,954
Liabilities
Account Payables 534,524 777,862 432,889 499,962
Short Term Debt 313,033 290,565 269,386 126,905
Total Current Liabilities 1,899,286 1,829,899 1,505,088 1,824,049
Long Term Debt 336,718 649,751 939,642 602,505
Total Liabilities 2,236,004 2,479,650 2,444,730 2,426,554
Shareholders Equity
Retained Earnings -167,954,817 -154,566,728 -142,364,695 -130,329,181
Total Shareholders Equity 5,123,530 5,766,332 15,064,210 17,133,108
Balance Sheet (Annual) 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Assets
Cash and Cash Equivalents 5,501,261 5,441,978 14,532,943 17,072,419 9,861,575
Short Term Investments 0 0 0 0 0
Net Receivables 0 0 0 127,965 149,082
Inventory 0 0 0 0 0
Total Current Assets 5,949,800 6,225,788 15,090,566 18,157,007 10,351,738
Property Plant Equipment 1,278,066 1,898,283 2,295,913 1,137,936 201,339
Goodwill and Intangibles 550 1,100 1,650 2,200 56,954
Total Assets 7,359,534 8,245,982 17,508,940 19,417,954 10,668,916
Liabilities
Account Payables 534,524 777,862 432,889 499,962 337,678
Short Term Debt 313,033 290,565 269,386 126,905 42,543
Total Current Liabilities 1,899,286 1,829,899 1,505,088 1,824,049 1,375,226
Long Term Debt 336,718 649,751 939,642 602,505 0
Total Liabilities 2,236,004 2,479,650 2,444,730 2,426,554 1,375,226
Shareholders Equity
Retained Earnings -167,954,817 -154,566,728 -142,364,695 -130,329,181 -119,913,090
Total Shareholders Equity 5,123,530 5,766,332 15,064,210 17,133,108 9,430,604
Cash Flow Statement (Quarterly) 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Operating Activities
Net Income -13,388,089 -12,208,174 -12,029,786 -10,420,885
Depreciation & Amortization 339,559 359,057 240,892 123,685
Stock Based Compensation 415,234 1,219,370 1,051,898 750,621
Change in Working Capital 93,694 478,659 65,339 -251,110
Operating Cash Flow -7,645,532 -10,129,810 -10,505,128 -9,767,157
Investing Activities
Capital Expenditure 0 -250,867 -943,109 -349,193
Investments 0 -250,867 -943,109 -349,193
Investing Cash Flow 0 -250,867 -943,109 -349,193
Financing Activities
Debt Repayment 0 0 0 0
Common Stock Issued/Repurchased 3,539,907 1,322,383 8,914,718 17,367,974
Dividends Paid 0 0 0 0
Financing Cash Flow 7,727,384 1,287,605 8,914,718 17,367,974
Summary
Free Cash Flow -7,645,532 -10,380,677 -11,448,237 -10,116,350
Net Change in Cash 69,590 -9,090,965 -2,539,476 7,251,624
Cash Flow Statement (Annual) 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Operating Activities
Net Income -13,388,089 -12,208,174 -12,029,786 -10,420,885 -7,886,709
Depreciation & Amortization 339,559 359,057 240,892 123,685 39,939
Stock Based Compensation 415,234 1,219,370 1,051,898 750,621 779,421
Change in Working Capital 93,694 478,659 65,339 -251,110 309,690
Operating Cash Flow -7,645,532 -10,129,810 -10,505,128 -9,767,157 -6,764,940
Investing Activities
Capital Expenditure 0 -250,867 -943,109 -349,193 -59,881
Investments 0 -250,867 -943,109 -349,193 -59,881
Investing Cash Flow 0 -250,867 -943,109 -349,193 -59,881
Financing Activities
Debt Repayment 0 0 0 0 0
Common Stock Issued/Repurchased 3,539,907 1,322,383 8,914,718 17,367,974 7,260,869
Dividends Paid 0 0 0 0 0
Financing Cash Flow 7,727,384 1,287,605 8,914,718 17,367,974 7,128,342
Summary
Free Cash Flow -7,645,532 -10,380,677 -11,448,237 -10,116,350 -6,824,821
Net Change in Cash 69,590 -9,090,965 -2,539,476 7,251,624 303,521